Home/Pipeline/Vaxine Alzheimer’s Disease Vaccine

Vaxine Alzheimer’s Disease Vaccine

Alzheimer’s Disease

PreclinicalActive

Key Facts

Indication

Alzheimer’s Disease

Phase

Preclinical

Status

Active

Company

AI‑enhanced vaccine developer using the Advax™ adjuvant platform for infectious disease and immunotherapy.

Drug	Company	Phase	Status
RASTRUM™ 3D Alzheimer’s Disease Model	Inventia Life Science	Pre‑clinical	Active
SPC-14	Silo Pharma	Preclinical	Research
Masitinib	AB Science	Phase 3	Active
Leronlimab	CytoDyn	Phase 1	Phase in progress
Sovateltide	Pharmazz	Preclinical	Active
Alzheimer's Drug	Dawah Pharmaceuticals	Development	Active
Alzheimer’s Clinical Trials	Boston Clinical Trials	Not Specified (Typically Phase 2-3)	Active
ONO-2020	Deciphera Pharmaceuticals	Phase 2	Active
Blarcamesine (ANAVEX®2-73)	Anavex Life Sciences	Phase 2b/3	Ongoing